New basic science and clinical research identifies TAU, the same protein studied in the development of Alzheimer’s, as a biomarker for glioma development.
Optical imaging and artificial intelligence are making brain tumor diagnosis quicker and more accurate.
People with medication-resistant epilepsy haven’t had many options. Now, a minimally invasive procedure uses lasers to stop the seizures.
How a new research initiative is empowering U-M physician-scientists to fight DIPG, one of the deadliest brain cancers, in innovative ways.